Page 1

November 16 , 2021 PAVmed PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results Conference call to be held today at 4:30 PM EDT NEW YORK -- ( BUSINESS WIRE ) -- PAVmed Inc. ( Nasdaq : PAVM , PAVMZ ) ( “ PAVmed ” ) , a highly differentiated , multi - product , commercial - stage medical device company , and its majority - owned subsidiary Lucid Diagnostics Inc. ( Nasdaq : LUCD ) ( “ Lucid ” ) , a commercial - stage cancer prevention diagnostics company today provided a joint business update for the companies and discussed preliminary financial results for the six and nine months ended September 30 , 2021 . This press release features multimedia . View the full release here : https://www.businesswire.com/news/home/20211116006357/en/ " The third quarter and recent weeks have proved to be an exciting time for our companies almost certainly the most important in PAVmed's corporate history , " said Lishan Aklog , M.D. , PAVmed's Chairman and Chief Executive Officer and Lucid's Chairman and Chief Executive Officer . " Lucid is now a Nasdaq - listed public company having raised sufficient capital to execute on its growth strategy and drive commercialization in a $ 25 billion - dollar addressable company . PAVmed's equity stake in Lucid actually increased from approximately 73 % to 76 % post - IPO as a result of PAVmed converting debt into equity immediately prior to consummation of the IPO . " " PAVmed and Lucid are both in a very strong financial position with over $ 90 million in cash between them . With Lucid now fully financed and self - sufficient , PAVmed no longer has to raise and spend capital , and dilute its shareholders , to finance Lucid's operations . We can deploy PAVmed's capital to advance and commercialize its other key products and expand our portfolio . As the majority shareholder PAVmed will continue to consolidate Lucid's financials . I am also excited that we have crossed another small but important milestone . PAVmed and Lucid are no longer pre - revenue companies , with both for the first time recognizing modest revenue for the third quarter . " Conference Call and Webcast A conference call and webcast for today's business update and third quarter 2021 financial results will take place at 4:30 PM EDT . To access the conference call , listeners should dial 877-407-3982 toll - free in the U.S. or 201-493-6780 , and ask to join the " PAVmed , Inc. Business Update Conference Call " . The conference call will be available live via webcast and for replay at the investor relations section of the Company's website at www.pavmed.com . Following the conclusion of the conference call , a replay will be available for one week and can be accessed by dialing 844-512-2921 toll - free in the U.S. or 412-317 6671 , followed by the PIN number : 13724402 .